These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 14727370

  • 1. [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients].
    Szulc A, Galińska B, Tarasów E, Walecki J, Dzienis W, Kubas B, Czernikiewicz A.
    Psychiatr Pol; 2003; 37(6):977-88. PubMed ID: 14727370
    [Abstract] [Full Text] [Related]

  • 2. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [Abstract] [Full Text] [Related]

  • 3. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).
    Szulc A, Galinska B, Tarasow E, Dzienis W, Kubas B, Konarzewska B, Walecki J, Alathiaki AS, Czernikiewicz A.
    Pharmacopsychiatry; 2005 Sep; 38(5):214-9. PubMed ID: 16189748
    [Abstract] [Full Text] [Related]

  • 4. Relationship between frontal N-acetylaspartate and cognitive deficits in first-episode schizophrenia.
    Galińska B, Szulc A, Tarasów E, Kubas B, Dzienis W, Siergiejczyk L, Czernikiewicz A, Walecki J.
    Med Sci Monit; 2007 May; 13 Suppl 1():11-6. PubMed ID: 17507879
    [Abstract] [Full Text] [Related]

  • 5. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of right thalamus and temporal cortex metabolite levels of drug-naive first-episode psychotic and chronic schizophrenia in patients].
    Başoğlu C, Cetin M, Oner O, Ebrinç S, Semiz UB, Kandilcioğlu H, Silit E, Kizilkaya E.
    Turk Psikiyatri Derg; 2006 Dec; 17(2):85-91. PubMed ID: 16755408
    [Abstract] [Full Text] [Related]

  • 7. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
    Tanaka Y, Obata T, Sassa T, Yoshitome E, Asai Y, Ikehira H, Suhara T, Okubo Y, Nishikawa T.
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
    [Abstract] [Full Text] [Related]

  • 8. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
    Szulc A, Galińska B, Tarasów E, Kubas B, Dzienis W, Konarzewska B, Poplawska R, Tomczak AA, Czernikiewicz A, Walecki J.
    Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880
    [Abstract] [Full Text] [Related]

  • 9. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
    Wood SJ, Berger GE, Lambert M, Conus P, Velakoulis D, Stuart GW, Desmond P, McGorry PD, Pantelis C.
    Arch Gen Psychiatry; 2006 Sep; 63(9):969-76. PubMed ID: 16952999
    [Abstract] [Full Text] [Related]

  • 10. Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.
    He ZL, Deng W, Li ML, Chen ZF, Collier DA, Ma X, Li T.
    Early Interv Psychiatry; 2012 May; 6(2):166-75. PubMed ID: 21951785
    [Abstract] [Full Text] [Related]

  • 11. Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia.
    Galińska B, Szulc A, Tarasów E, Kubas B, Dzienis W, Czernikiewicz A, Walecki J.
    Med Sci Monit; 2009 Feb; 15(2):CR82-88. PubMed ID: 19179972
    [Abstract] [Full Text] [Related]

  • 12. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.
    Jessen F, Scherk H, Träber F, Theyson S, Berning J, Tepest R, Falkai P, Schild HH, Maier W, Wagner M, Block W.
    Schizophr Res; 2006 Oct; 87(1-3):81-8. PubMed ID: 16842971
    [Abstract] [Full Text] [Related]

  • 13. The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients.
    Gonul AS, Kitis O, Ozan E, Akdeniz F, Eker C, Eker OD, Vahip S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):120-5. PubMed ID: 16236417
    [Abstract] [Full Text] [Related]

  • 14. Neuropsychological correlates of basal ganglia and medial temporal lobe NAA/Cho reductions in traumatic brain injury.
    Ariza M, Junqué C, Mataró M, Poca MA, Bargalló N, Olondo M, Sahuquillo J.
    Arch Neurol; 2004 Apr; 61(4):541-4. PubMed ID: 15096403
    [Abstract] [Full Text] [Related]

  • 15. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
    Jensen JE, Miller J, Williamson PC, Neufeld RW, Menon RS, Malla A, Manchanda R, Schaefer B, Densmore M, Drost DJ.
    Psychiatry Res; 2006 Mar 31; 146(2):127-35. PubMed ID: 16497488
    [Abstract] [Full Text] [Related]

  • 16. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
    Jessen F, Gür O, Block W, Ende G, Frölich L, Hammen T, Wiltfang J, Kucinski T, Jahn H, Heun R, Maier W, Kölsch H, Kornhuber J, Träber F.
    Neurology; 2009 May 19; 72(20):1735-40. PubMed ID: 19451528
    [Abstract] [Full Text] [Related]

  • 17. Decrease of NAA with aging outside the seizure focus in mesial temporal lobe epilepsy--a proton-MRS study at 3 Tesla.
    Riederer F, Bittsanský M, Lehner-Baumgartner E, Baumgartner C, Mlynárik V, Gruber S, Moser E, Kaya M, Serles W.
    Brain Res; 2007 Nov 07; 1179():131-9. PubMed ID: 17936253
    [Abstract] [Full Text] [Related]

  • 18. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J, Levitt J, Caplan R, Asarnow R, McCracken JT, Toga AW, Alger JR.
    Neuroimage; 2004 Apr 07; 21(4):1781-9. PubMed ID: 15050598
    [Abstract] [Full Text] [Related]

  • 19. Adolescent anorexia nervosa: cross-sectional and follow-up frontal gray matter disturbances detected with proton magnetic resonance spectroscopy.
    Castro-Fornieles J, Bargalló N, Lázaro L, Andrés S, Falcon C, Plana MT, Junqué C.
    J Psychiatr Res; 2007 Dec 07; 41(11):952-8. PubMed ID: 17112540
    [Abstract] [Full Text] [Related]

  • 20. Are personality traits of juvenile myoclonic epilepsy related to frontal lobe dysfunctions? A proton MRS study.
    de Araújo Filho GM, Lin K, Lin J, Peruchi MM, Caboclo LO, Guaranha MS, Guilhoto LM, Carrete H, Yacubian EM.
    Epilepsia; 2009 May 07; 50(5):1201-9. PubMed ID: 19400877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.